Literature DB >> 24974838

Helicobacter pylori infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension.

Jannis Kountouras1, Georgia Deretzi1, Christos Zavos1, Panagiotis Katsinelos1.   

Abstract

Entities:  

Year:  2014        PMID: 24974838      PMCID: PMC4073038     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
In their retrospective series, Sathar et al [1] concluded that there is significant association between Helicobacter pylori infection (Hp-I) and portal hypertensive gastropathy (PHG) in cirrhotic patients, also related to PHG severity, thereby necessitating Hp eradication. Apart from PHG, hepatic encephalopathy (HE) is another complication of portal hypertension that remains a major cause of morbidity in cirrhotic patients [2]. HE encompasses a spectrum of neuropsychiatric disorders related to liver failure and the mechanisms responsible for the neurological alterations in HE begin to emerge [3]. Hepatitis B (HBV) and C (HCV) infections are among the commonest causes of liver cirrhosis worldwide; Hp-I is strongly associated with HBV- and HCV-related cirrhosis in Europe; Hp-I is more common in cirrhotic patients with HE than in those without [4]; HE is not a fully reversible condition and the mechanism behind the lack of reversibility of the neurocognitive status despite the resolution of mental status changes is unclear [5]; and cognitive dysfunction is a factor associated with falls in cirrhotic patients, though further studies are warranted to address the mechanisms implicated in this predisposition and to design preventive strategies [5]. In this regard, Hp-I has been frequently detected in cognitive impairment and Alzheimer’s disease (AD) [6] and we found that Hp eradication may positively influence AD manifestations at five-year clinical endpoints [7], thereby supporting a role for this common infection in the pathobiology of the disease. Hp may be involved in the pathophysiology of both HE and post-HE persistent cognitive impairment by several mechanisms [7], including the release of proinflammatory/vasoactive substances, involved, through blood-brain-barrier disruption, in a number of vascular disorders including AD, which can lead to long-term neurologic deficits [4,5]. It is therefore important to know if the authors have considered the association between Hp-I, HE and/or post-HE cognitive impairment in their cirrhotic patients.
  7 in total

1.  Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis.

Authors:  Jannis Kountouras; Christos Zavos; Georgia Deretzi; Elizabeth Vardaka; Marina Boziki; Emmanouel Gavalas; George Kouklakis; Panagiotis Katsinelos; Ioannis Venizelos; Christina Nikolaidou; Stergios A Polyzos; Evaggelia Giartza-Taxidou
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

2.  Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction.

Authors:  Jannis Kountouras; Christos Zavos; Georgia Deretzi; Emmanouel Gavalas; Stergios Polyzos; Panagiotis Katsinelos; Nikolaos Grigoriadis; Evangelos Koutlas; Jobst Rudolf; Iakovos Tsiptsios
Journal:  J Neuroimmunol       Date:  2010-10-20       Impact factor: 3.478

3.  Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Jannis Kountouras; Christos Zavos; Georgia Deretzi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-17       Impact factor: 11.382

4.  Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients.

Authors:  Jannis Kountouras; Marina Boziki; Emmanouel Gavalas; Christos Zavos; Georgia Deretzi; Stavros Chatzigeorgiou; Panagiotis Katsinelos; Nikolaos Grigoriadis; Evangelia Giartza-Taxidou; Ioannis Venizelos
Journal:  Cogn Behav Neurol       Date:  2010-09       Impact factor: 1.600

5.  Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy.

Authors:  Wim Laleman; Macarena Simon-Talero; Geert Maleux; Mercedes Perez; Koen Ameloot; German Soriano; Jordi Villalba; Juan-Carlos Garcia-Pagan; Marta Barrufet; Rajiv Jalan; Jocelyn Brookes; Evangelos Thalassinos; Andrew K Burroughs; Juan Cordoba; Frederik Nevens
Journal:  Hepatology       Date:  2013-05-01       Impact factor: 17.425

Review 6.  Hepatic encephalopathy: effects of liver failure on brain function.

Authors:  Vicente Felipo
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

7.  Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy.

Authors:  Shanid Abdul Sathar; Sojan George Kunnathuparambil; Srijaya Sreesh; Premaletha Narayanan; Kattoor Ramakrishnan Vinayakumar
Journal:  Ann Gastroenterol       Date:  2014
  7 in total
  2 in total

1.  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.

Authors:  Jannis Kountouras; Stergios A Polyzos; Panagiotis Katsinelos; Sotiris Anastasiadis; Dimitri Tzivras; Michael Doulberis; Ioannis Venizelos; Elizabeth Vardaka; Constantinos Kountouras; Georgia Deretzi
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

2.  Helicobacter pylori infection among patients with liver cirrhosis.

Authors:  Joanna Pogorzelska; Magda Łapińska; Alicja Kalinowska; Tadeusz W Łapiński; Robert Flisiak
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-10       Impact factor: 2.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.